SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+44.07%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$980M
AUM Growth
+$980M
(+22%)
Cap. Flow
-$118M
Cap. Flow
% of AUM
-12%
Top 10 Holdings %
Top 10 Hldgs %
66.15%
Holding
75
New
12
Increased
8
Reduced
18
Closed
12
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$13M |
| 2 |
Novo Nordisk
NVO
|
$13M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$9.96M |
| 4 |
Halozyme
HALO
|
$6.46M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$5.75M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$58.9M |
| 2 |
PDS Biotechnology
PDSB
|
$20M |
| 3 |
Sanofi
SNY
|
$14.2M |
| 4 |
Gilead Sciences
GILD
|
$13.3M |
| 5 |
Incyte
INCY
|
$11.6M |
Sector Composition
| 1 | Healthcare | 88.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Xencor
XNCR
$580M
| $6.52M | 0.63% | 209,907 +10,225 | +5% | +$318K |
|
|
27
Halozyme
HALO
$8.56B
| $6.46M | 0.62% | +401,329 | New | +$6.46M |
|
|
BHVN
28
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.43M | 0.62% | 124,952 +27,507 | +28% | +$1.42M |
|
|
BPMC
29
DELISTED
Blueprint Medicines
BPMC
| $5.75M | 0.55% | +71,866 | New | +$5.75M |
|
30
Heron Therapeutics
HRTX
$207M
| $5.71M | 0.55% | 233,651 -126,062 | -35% | -$3.08M |
|
31
Savara
SVRA
$567M
| $5.65M | 0.54% | 766,672 +12,300 | +2% | +$90.7K |
|
|
RETA
32
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.56M | 0.54% | 65,031 -92,953 | -59% | -$7.95M |
|
|
ICPT
33
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.02M | 0.48% | 44,918 -9,554 | -18% | -$1.07M |
|
|
DCPH
34
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.98M | 0.48% | 214,604 -50,871 | -19% | -$1.18M |
|
|
ORTX
35
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $4.94M | 0.48% | 276,083 +53,465 | +24% | +$956K |
|
|
36
Incyte
INCY
$16.5B
| $4.57M | 0.44% | 53,097 -135,400 | -72% | -$11.6M |
|
|
KDMN
37
DELISTED
Kadmon Holdings, Inc.
KDMN
| $4.41M | 0.43% | 1,671,770 +20,598 | +1% | +$54.4K |
|
38
Synlogic
SYBX
$17M
| $4.36M | 0.42% | 574,972 | – | – |
|
39
Akebia Therapeutics
AKBA
$833M
| $4.23M | 0.41% | +516,761 | New | +$4.23M |
|
40
Insmed
INSM
$28.8B
| $4.07M | 0.39% | +140,057 | New | +$4.07M |
|
41
Fate Therapeutics
FATE
$120M
| $3.58M | 0.35% | 203,742 -26,071 | -11% | -$458K |
|
|
GWPH
42
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.37M | 0.32% | 20,000 -10,000 | -33% | -$1.69M |
|
43
FibroGen
FGEN
$47.8M
| $3.21M | 0.31% | 59,017 -20,983 | -26% | -$1.14M |
|
|
FOMX
44
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.12M | 0.3% | 832,293 | – | – |
|
45
XBiotech
XBIT
$96.3M
| $2.88M | 0.28% | +261,391 | New | +$2.88M |
|
46
KALA BIO
KALA
$78.8M
| $2.86M | 0.28% | 345,346 -100,170 | -22% | -$828K |
|
47
TG Therapeutics
TGTX
$4.65B
| $2.83M | 0.27% | +351,811 | New | +$2.83M |
|
|
OTIC
48
DELISTED
Otonomy, Inc.
OTIC
| $2.69M | 0.26% | 1,023,865 | – | – |
|
|
ARQL
49
DELISTED
Arqule Inc
ARQL
| $1.7M | 0.16% | +355,725 | New | +$1.7M |
|
|
CLVS
50
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.65M | 0.16% | 66,635 -221,134 | -77% | -$5.49M |
|